Download Free Sample Report

Gastric Motility Disorder Drug Market, Global Outlook and Forecast 2022-2028

Gastric Motility Disorder Drug Market, Global Outlook and Forecast 2022-2028

  • Published on : 22 July 2022
  • Pages :71
  • Report Code:SMR-7225645

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

This report contains market size and forecasts of Gastric Motility Disorder Drug in global, including the following market information:
Global Gastric Motility Disorder Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gastric Motility Disorder Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Gastric Motility Disorder Drug companies in 2021 (%)
The global Gastric Motility Disorder Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Velusetrag Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastric Motility Disorder Drug include Theravance, Inc., Helsinn Healthcare S.A., Concert Pharmaceuticals, Inc., Targacept, Inc. and ChironWells GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastric Motility Disorder Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastric Motility Disorder Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gastric Motility Disorder Drug Market Segment Percentages, by Type, 2021 (%)
Velusetrag
Ipamorelin
TD-8954
Others
Global Gastric Motility Disorder Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gastric Motility Disorder Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Home Use
Global Gastric Motility Disorder Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Gastric Motility Disorder Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastric Motility Disorder Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gastric Motility Disorder Drug revenues share in global market, 2021 (%)
Key companies Gastric Motility Disorder Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Gastric Motility Disorder Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Theravance, Inc.
Helsinn Healthcare S.A.
Concert Pharmaceuticals, Inc.
Targacept, Inc.
ChironWells GmbH